Platinum Investment Management LTD Aerie Pharmaceuticals Inc Transaction History

Platinum Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$12.0 - $16.13 $1.37 Million - $1.84 Million	-113,842 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $198,339 - $280,944	11,193 Added 10.9%	113,842 $2.75 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $888,558 - $1.35 Million	48,265 Added 88.75%	102,649 $1.97 Million
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $657,155 - $1.09 Million	22,684 Added 71.56%	54,384 $1.61 Million
Q3 2018 Nov 15, 2018	SELL	$56.15 - $73.9 $331,285 - $436,010	-5,900 Reduced 15.69%	31,700 $1.95 Million

Q3 2017 Nov 14, 2017	SELL	$48.6 - $60.1 $238,140 - $294,490	-4,900 Reduced 11.53%	37,600 $1.83 Million
Q2 2017 Aug 15, 2017	BUY	N/A	42,500	42,500 $2.23 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.